Formation of compound I by the reaction of catalase with peroxoacetic acid

Por Jones, Peter, Middlemiss, D. N.
Publicado em 1972

Relationship between inhibition of cyclic AMP production in Chinese hamster ovary cells expressing the rat D2(444) receptor and antagonist/agonist binding ratios.

Por Harley, E. A., Middlemiss, D. N., Ragan, C. I.
Publicado em 1995

Further evidence for an interaction of propranolol with the central 5-hydroxytryptamine (5-HT) receptor [proceedings]

Por Connell, D. J., Middlemiss, D. N., Stone, M. A.
Publicado em 1980

The interaction of tyramine with a single dose of tranylcypromine in healthy volunteers.

Por Peet, M, Yates, R A, Carroll, J A, Middlemiss, D N
Publicado em 1981

Pharmacological characterization of extracellular acidification rate responses in human D(2(long)), D(3) and D(4.4) receptors expressed in Chinese hamster ovary cells

Por Coldwell, M C, Boyfield, I, Brown, A M, Stemp, G, Middlemiss, D N
Publicado em 1999

Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.

Por Moser, P. C., Tricklebank, M. D., Middlemiss, D. N., Mir, A. K., Hibert, M. F., Fozard, J. R.
Publicado em 1990

Comparative pharmacology of recombinant rat AT1A, AT1B and human AT1 receptors expressed by transfected COS-M6 cells.

Por Balmforth, A. J., Bryson, S. E., Aylett, A. J., Warburton, P., Ball, S. G., Pun, K. T., Middlemiss, D., Drew, G. M.
Publicado em 1994

Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype.

Por McAllister, G, Charlesworth, A, Snodin, C, Beer, M S, Noble, A J, Middlemiss, D N, Iversen, L L, Whiting, P
Publicado em 1992

Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT(1) and 5-HT(2) receptors

Por Watson, J, Brough, S, Coldwell, M C, Gager, T, Ho, M, Hunter, A J, Jerman, J, Middlemiss, D N, Riley, G J, Brown, A M
Publicado em 1998

L-694,247: a potent 5-HT1D receptor agonist.

Por Beer, M. S., Stanton, J. A., Bevan, Y., Heald, A., Reeve, A. J., Street, L. J., Matassa, V. G., Hargreaves, R. J., Middlemiss, D. N.
Publicado em 1993

Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR

Por Smart, D, Jerman, J C, Brough, S J, Rushton, S L, Murdock, P R, Jewitt, F, Elshourbagy, N A, Ellis, C E, Middlemiss, D N, Brown, F
Publicado em 1999

SB-224289–a novel selective (human) 5-HT(1B) receptor antagonist with negative intrinsic activity

Por Selkirk, J V, Scott, C, Ho, M, Burton, M J, Watson, J, Gaster, L M, Collin, L, Jones, B J, Middlemiss, D N, Price, G W
Publicado em 1998

Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist.

Por Hilditch, A., Hunt, A. A., Gardner, C. J., Twissell, D. J., Polley, J., Travers, A., Drew, G. M., Middlemiss, D., Ross, B. C., Robertson, M. J.
Publicado em 1994

Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.

Por Robertson, M. J., Barnes, J. C., Drew, G. M., Clark, K. L., Marshall, F. H., Michel, A., Middlemiss, D., Ross, B. C., Scopes, D., Dowle, M. D.
Publicado em 1992

SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue

Por Watson, J, Roberts, C, Scott, C, Kendall, I, Collin, L, Day, N C, Harries, M H, Soffin, E, Davies, C H, Randall, A D, Heightman, T, Gaster, L, Wyman, P, Parker, C, Price, G W, Middlemiss, D N
Publicado em 2001